| 國立臺灣大學 |
1994-12 |
Clindamycin resistance transfer in Bacteroides fragilis
|
Teng, LJ; Liaw, SJ; Luh, KT; Ho, SW. |
| 臺大學術典藏 |
2020-06-30T06:14:06Z |
Clindamycin resistance transfer in Bacteroides fragilis.
|
Lee-Jene Teng;Liaw S.J.;Luh K.T.;Ho S.W.; LEE-JENE TENG; Liaw S.J.; Luh K.T.; Ho S.W. |
| 臺大學術典藏 |
2021-05-26T03:35:59Z |
Clindamycin resistance transfer in Bacteroides fragilis.
|
Teng L.J.; Liaw S.J.; KWEN-TAY LUH; Ho S.W. |
| 國立臺灣大學 |
1994 |
Clindamycin trsistance transfer in Bacteroides fragilis
|
鄧麗珍; 廖淑貞; 陸坤泰; 何憲武; TENG, LEE-JENE; LIAW, SHWU-JEN; LUH, KWEN-TAY; HO, SHEN-WU |
| 國立臺灣大學 |
1994 |
Clinial experience of Posterior Urethral Valves
|
陳文孝; 賴明坤; 林季珍; 朱聖賢; CHEN, WEN-HSIANG; LAI, MING-KUEN; LIN, GHI-JEN; CHU, SHENG-HSIEN |
| 中國醫藥大學 |
2008-06-26 |
Clinial-scal analysis of urinary nucleosides as tumor markers in human colorectal cancer by HPLC/ESI tandem mass spectrometry using ion trap mass spectrometer
|
許維儀(Wei-Yi Hsu); 蔡輔仁(Fuu-Jen Tsai); 賴建成(Chien-Chen Lai)* |
| 國立臺灣大學 |
2013 |
Clinic Applications in Assaying Ultra-Low-Concentration Bio-Markers Using HTS SQUID-Based AC Magnetosusceptometer
|
Yang, S.Y.; Chieh, J.J.; Yang, C.C.; Liao, S.H.; Chen, H.H.; Horng, H.E.; Yang, H.C.; Hong, C.Y.; Chiu, M.J.; Chen, T.F.; Huang, K.W.; Wu, C.C.; 吳造中; 邱銘章; 黃凱文; 陳達夫 |
| 國立臺灣大學 |
2013 |
Clinic Applications in Assaying Ultra-Low-Concentration Bio-Markers Using HTS SQUID-Based AC Magnetosusceptometer
|
Yang, S. Y.; Chieh, J. J.; Yang, C. C.; Liao, S. H.; Chen, H. H.; Horng, H. E.; Yang, H. C.; Hong, C. Y.; Chiu, M. J.; Chen, T. F.; Huang, K. W.; Wu, C. C.; 吳造中; 邱銘章; 黃凱文; 陳達夫 |
| 國立成功大學 |
2007-10 |
Clinic appointment attendance for sexually transmitted infection screening among Filipina sex workers: A multilevel analysis
|
Chiao, Chi; Morisky, D. E.; Ksobiech, K.; Masson, C. L.; Malow, R. M. |
| 嘉南藥理大學 |
2009 |
Clinica Chimica Acta
|
Elsevier SDOL |
| 臺北醫學大學 |
2005 |
Clinical & Endocrinological Aspects of Prostate Cancer Management
|
葉劭德; Yeh SD |
| 國立臺灣大學 |
2015 |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
Yang, James C-H; Sequist, Lecia V.; Geater, Sarayut Lucien; Tsai, Chun-Ming; Mok, Tony Shu Kam; Schuler, Martin; Yamamoto, Nobuyuki; Yu, Chong-Jen; Ou, Sai-Hong I.; Zhou, Caicun; Massey, Daniel; Zazulina, Victoria; Wu, Yi-Long; 楊志新; 余忠仁 |
| 臺大學術典藏 |
2020-05-26T09:26:57Z |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
CHIH-HSIN YANG; Sequist L.V; Geater S.L; Tsai C.-M; Mok T.S.K; Schuler M; Yamamoto N; Yu C.-J; Ou S.H.I; Zhou C; Massey D; Zazulina V; Wu Y.-L.; Wu Y.-L.;Zazulina V;Massey D;Zhou C;Ou S.H.I;Yu C.-J;Yamamoto N;Schuler M;Mok T.S.K;Tsai C.-M;Geater S.L;Sequist L.V;Chih-Hsin Yang |
| 臺大學術典藏 |
2022-06-27T07:01:36Z |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
Yang J.C.-H.; Sequist L.V.; Geater S.L.; Tsai C.-M.; Mok T.S.K.; Schuler M.; Yamamoto N.; CHONG-JEN YU; Ou S.H.I.; Zhou C.; Massey D.; Zazulina V.; Wu Y.-L. |
| 臺大學術典藏 |
2020-05-26T09:26:26Z |
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations
|
Nakagawa K.;Fukuoka M;Morita S;Shimazaki M;Kaneko Y;Akazawa R;Takeda K;Nakagawa T;Kang J.-H;Takeda K;Inoue A;Kiura K;Kim S.-W;Nishio M;Chih-Hsin Yang;Tsai C.-M;Azuma K;Park K;Seto T;Hayashi H;Nokihara H;Murakami H; Murakami H; Nokihara H; Hayashi H; Seto T; Park K; Azuma K; Tsai C.-M; CHIH-HSIN YANG; Nishio M; Kim S.-W; Kiura K; Inoue A; Takeda K; Kang J.-H; Nakagawa T; Takeda K; Akazawa R; Kaneko Y; Shimazaki M; Morita S; Fukuoka M; Nakagawa K. |
| 臺大學術典藏 |
2014 |
Clinical activity of metronomic chemotherapy in liver cancers
|
Hsu C.-H.; Cheng A.-L.; Yu-Yun Shao;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
Clinical activity of metronomic chemotherapy in liver cancers
|
Shao Y.-Y.;Cheng A.-L.;Chih-Hung Hsu; Shao Y.-Y.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2021-08-31T06:42:23Z |
Clinical activity of metronomic chemotherapy in liver cancers
|
Shao Y.-Y.; ANN-LII CHENG; Hsu C.-H. |
| 嘉南藥理大學 |
2009 |
Clinical Acupuncture and Oriental Medicine
|
Elsevier SDOL |
| 臺大學術典藏 |
2021-07-08T01:20:51Z |
Clinical Adverse Events Associated with Sodium-Glucose Cotransporter 2 Inhibitors: A Meta-Analysis Involving 10 Randomized Clinical Trials and 71 553 Individuals
|
Lin, Donna Shu-Han; Lee, Jen-Kuang; WEN-JONE CHEN |
| 臺大學術典藏 |
2022-03-07T07:05:24Z |
Clinical Adverse Events Associated with Sodium-Glucose Cotransporter 2 Inhibitors: A Meta-Analysis Involving 10 Randomized Clinical Trials and 71 553 Individuals
|
Lin D.S.-H.; JEN-KUANG LEE; Chen W.-J. |
| 國家衛生研究院 |
2014-12 |
Clinical aggressiveness of myxofibrosarcomas associates with down-regulation of p12cdk2ap1: Prognostic implication of a putative tumor suppressor that induces cell cycle arrest and apoptosis via mitochondrial pathway
|
Li, CF;Huang, HY;Wu, WR;Liang, SS;Chen, YL;Chen, LR;Peng, YT;Lee, HC;Shiue, YL |
| 國立成功大學 |
2014-12 |
Clinical Aggressiveness of Myxofibrosarcomas Associates with Down-Regulation of p12CDK2AP1: Prognostic Implication of a Putative Tumor Suppressor that Induces Cell Cycle Arrest and Apoptosis Via Mitochondrial Pathway
|
Li, Chien-Feng; Huang, Hsuan-Ying; Wu, Wen-Ren; Liang, Shih-Shin; Chen, Yi-Ling; Chen, Lih-Ren; Peng, Yu-Ting; Lee, Hui-Chieh; Shiue, Yow-Ling |
| 國立臺灣大學 |
2010 |
Clinical Alertness to Valproic Acid-Induced Hyperammonemia-Two Case Reports
|
單家祁; 謝明憲; 劉震鐘; 溫俊强; 劉智民; SHAN, JIA-CHI; HSIEH, MING-HSIEN; LIU, CHEN-CHUNG; WEN, CHUN-CHIANG; LIU, CHIH-MIN |
| 臺大學術典藏 |
2018-09-10T08:08:53Z |
Clinical alertness to valproic acid-induced hyperammonemia-two case reports
|
Shan, J.C.;Hsieh, M.H.;Liu, C.C.;Wen, C.C.;Liu, C.M.; CHEN-CHUNG LIU; CHIH-MIN LIU |
